of Restenosis To the Editor: We would like to point out several issues related to citations of the scientific literature in an article by Yamasaki et al.1 We would like to emphasize that quinoxalines were the first compounds showing excellent efficacy in inhibiting balloon injury–induced stenosis in pigs and rats. Reference 20 in the article by Yamasaki et al, which describes this study, is not...

Schwannomas, although benign, can be fatal or give rise to significant morbidity due to an unpredictable growth rate. They can reoccur after surgery or radiation, current treatments each with significant inherent risks. These risks are further amplified in neurofibromatosis type 2 (NF2), a germ line predisposition syndrome characterized by multiple schwannomas, underlying the need for biologica...

Using human MSCs (mesenchymal stem cells) lacking VEGF (vascular endothelial growth factor) receptors, we show that the pro-angiogenic receptor neuropilin-1 associates with phosphorylated PDGFRs [PDGF (platelet-derived growth factor) receptors], thereby regulating cell signalling, migration, proliferation and network assembly. Neuropilin-1 co-immunoprecipitated and co-localized with phosphoryla...

In this study 8 genes of growth factors and their receptors were investigated that are known to play a significant role in signaling pathways involved in the ontogenetic, but also tumorigenic, development of breast and mammary glands. Differential expression of fibroblast growth factor receptor 2 (FGFR2), GH receptor (GHR), hepatocyte growth factor (HGF), hepatocyte growth factor receptor (HGFR...

Submit Manuscript | http://medcraveonline.com Abbreviations: TERM: Tissue Engineering and Regenerative Medicine; GAG: Glycosaminoglycans; CEA: Cultured Epithelial Autograft; SCS: Stem Cells; MSCS: Mesenchymal Stem Cells, BMMSCS: Bone Marrow-Derived Mesenchymal Stem Cells; ADSCS: Adipose -Derived Mesenchymal Stem Cells; ECM: Extracellular Matrix; VEFG: Vascular Endothelial Growth Factor; PDGF: P...

Cell-free plasma-derived serum (PDS) is deficient in the platelet-derived growth factor and will not support the growth of 3T3 cells, fibroblasts, or smooth muscle cells. However, when PDS-containing medium is preincubated with endothelial cells, the medium becomes modified so that it will support growth. The activity produced by the endothelial cells results from a polypeptide of 10,000 to 30,...

Stimulation of thymidine incorporation by basic fibroblast growth factor or epidermal growth factor treatment of cultured quiescent smooth muscle cells (rat and human) was attenuated by the concomitant treatment with interleukin-1, in the presence of indomethacin. Platelet-derived growth factor-AB and -BR-induced thymidine incorporation was not inhibited by the presence of the cytokine under si...

Stimulation of thymidine incorporation by basic fibroblast growth factor or epidermal growth factor treatment of cultured quiescent smooth muscle cells (rat and human) was attenuated by the concomitant treatment with interleukin-1 beta in the presence of indomethacin. Platelet-derived growth factor-AB and -BB-induced thymidine incorporation was not inhibited by the presence of the cytokine unde...

Abstract Platelet derivatives are commonly used in wound healing and tissue regeneration. Different procedures of platelet preparation may differentially affect growth factor release and cell growth. Preparation of platelet-rich fibrin (PRF) is accompanied by release of growth factors, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and transforming gr...